Predict your next investment

HEALTHCARE | Drug Development
therabron.com

See what CB Insights has to offer

Stage

Debt | Dead

Total Raised

$21.62M

Last Raised

$2.33M

About Therabron Therapeutics

Therabron Therapeutics, forrmerly Clarassance, is a clinical-stage biotechnology company that develops protein drugs to treat respiratory diseases. The company's products aim to restore the natural immune balance in the lungs of respiratory patients through the administration of synthetic human CC10 proteins. The family of CC10 proteins, also known as secretoglobins, have the potential to change the course of acute and chronic respiratory diseases, representing large markets into which few truly novel drugs have been introduced in the past several decades. Therabron's products have the potential to be first-to-market, first-in-class, disease-modifying, break-through biologics.

Therabron Therapeutics Headquarter Location

9430 Key West Avenue #125

Rockville, Maryland, 20850,

United States

240-205-7271

Latest Therabron Therapeutics News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Therabron Therapeutics Patents

Therabron Therapeutics has filed 8 patents.

The 3 most popular patent topics include:

  • Protein domains
  • Allergology
  • Inflammations
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/17/2016

5/21/2019

Proteins, Cell biology, Protein domains, Molecular biology, Clusters of differentiation

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/17/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

5/21/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Proteins, Cell biology, Protein domains, Molecular biology, Clusters of differentiation

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.